Nuvalent (NUVL) Cash & Equivalents (2020 - 2026)
Nuvalent's Cash & Equivalents was $159.73 million in Q1 2026, up 32.2% from $120.84 million a year earlier but down 39.0% from the prior quarter.
Powered by 
Analysis
Nuvalent (NUVL) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Nuvalent came in at $261.75 million, up 79.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 90.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $145.69 million in FY2024 (-56.6%), $335.39 million in FY2023 (+38.7%), $241.81 million in FY2022 (+252.9%) and $68.53 million in FY2021 (+563.2%).
- Quarterly Cash & Equivalents has moved between $67.27 million (Q1 2022) and $369.24 million (Q3 2024) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in six of the last eight quarters, with growth averaging 50.1%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 563.2%); the worst was Q3 2022 (a decline of 69.0%).
- Per Business Quant data, NUVL's Cash & Equivalents in the three quarters before Q1 2026 was $261.75 million (Q4 2025), $115.75 million (Q3 2025) and $127.47 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 159.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 159.73 Mn |
| Dec 31, 2025 | 261.75 Mn |
| Sep 30, 2025 | 115.75 Mn |
| Jun 30, 2025 | 127.47 Mn |
| Mar 31, 2025 | 120.84 Mn |
| Dec 31, 2024 | 145.69 Mn |
| Sep 30, 2024 | 369.24 Mn |
| Jun 30, 2024 | 77.70 Mn |
| Mar 31, 2024 | 98.52 Mn |
| Dec 31, 2023 | 335.39 Mn |
| Sep 30, 2023 | 88.43 Mn |
| Jun 30, 2023 | 70.87 Mn |
| Mar 31, 2023 | 90.12 Mn |
| Dec 31, 2022 | 241.81 Mn |
| Sep 30, 2022 | 76.31 Mn |
| Jun 30, 2022 | 75.92 Mn |
| Mar 31, 2022 | 67.27 Mn |
| Dec 31, 2021 | 68.53 Mn |
| Sep 30, 2021 | 245.89 Mn |
| Dec 31, 2020 | 10.33 Mn |
API Access
Nuvalent Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUVL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NUVL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUVL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();